Clinical Trial Update: Evaluation of Single Session Stereotactic Body Radiotherapy [Phase 1, Phase 2]

View source ↗

Summary

Results from a Phase 1/2 trial evaluating single-session stereotactic body radiotherapy for spinal neoplasms have been completed and results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spinal Neoplasms

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Spinal Neoplasms | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2025-10-24